The Japanese gynecological device market will witness slow growth over the forecast period, primarily driven by increased patient awareness, physician preference for noninvasive techniques, and the…
The US diabetes care device market has shown strong recovery from the short-term negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the coming years. Market…
The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, an expanding patient population, and rising adoption of premium-priced drug-…
The Asia Pacific spinal implant market will continue to experience strong growth throughout the forecast period. The uptake of premium innovations such as 3-D printed implants, nonfusion…
Driven by the increasing prevalence of kidney diseases, aging population, product innovation, and patient awareness of urological treatments in this region, the European urological device market…
The European GI endoscopy device market is showing strong recovery from the short-term impacts of the COVID-19 pandemic and will continue to expand at a modest pace through 2032. Procedure volume…
The US endoscope service market is expected to grow slowly over the forecast period, with OEMs representing the majority of revenues owing to their ability to provide exact model loaner endoscopes…
The European market for breast implants and reconstruction devices will exhibit modest growth, driven by several key factors. The safety and aesthetic results of breast augmentation and…
The European TEO device market will see modest growth over the forecast period driven by growing adoption of minimally invasive treatment options like embolization. Additionally, the market will…
The European ENT device market is a relatively mature market, and overall growth will be driven mainly by the faster-growing nasal packing and balloon dilation device segments. Expansion of these…
Following the impact of the COVID-19 pandemic, the European spinal implant market experienced strong growth in 2022 as deferred procedures were rescheduled. The market will continue to experience…
Favorable demographics, investment in enabling technologies, uptake of premium-priced products, and increased availability and quality of surgeon training will help the market grow at a rapid pace…
The US sports medicine device market had been significantly impacted by treatment deferrals and the elective nature of sports medicine procedures following the COVID-19 pandemic; however, by 2022,…
Driven by product innovation, rising kidney stone prevalence, and an aging population, the market for US urological devices will grow at a modest rate through 2032 despite the significant impact of…